Effect of light and heat on the stability of montelukast in solution and in its solid state.
The chemical stability of montelukast (Monte) in solution and in its solid state was studied. A simultaneous measurement of Monte and its degradation products was determined using a selective HPLC method. The HPLC system comprised a reversed phase column (C18) as the stationary phase and a mixture of ammonium acetate buffer of pH 3.5 and methanol (15:85 v/v) as the mobile phase. The UV detection was conducted at 254 nm. Monte in solution showed instability when exposed to light leading to the formation of its cis-isomer as the major photoproduct. The rate of photodegradation of Monte in solution exposed to various light sources increases in the order of; sodium<neon<tungsten<daylight<UV (254 nm). The extent of photodegradation was influenced by solvent type, where Monte was found to be most stable in 70% methanol. In solid state, Monte showed more than 20% decrease in its potency after exposure to daylight for 1 week. Also unpacked Monte chewable tablets, exposed to daylight for 2 weeks, showed a decrease of about 10% with the formation of Monte S-oxide as a major photoproduct. On the other hand, Monte film-coated tablets either unpacked or in its immediate pack showed excellent stability under the same condition. The thermal stress testing study of Monte in solutions at 65 degrees C showed that it is highly stable in NaOH solution, while it degrades rapidly in both acidic and H2O2 solutions. The major degradation product in the latter solvent was Monte S-oxide and it was also detected as a major degradation product in Monte tablet dosage form during the incubation at 40 degrees C/75% RH for 6 months. Findings of this study have helped to understand the stability behavior of Monte and to establish the critical parameters, which may affect its analysis and manufacturing activities.
Al Omari
Mahmoud M
MM
The Jordanian Pharmaceutical Manufacturing Company, Naor, Jordan. momari@jpm.com.jo
Zoubi
Rufaida M
RM
Hasan
Enas I
EI
Khader
Tariq Z
TZ
Badwan
Adnan A
AA
D000085:Acetates / Q000737:chemistry*; D018927:Anti-Asthmatic Agents / Q000737:chemistry*; D002021:Buffers; D002851:Chromatography, High Pressure Liquid; D003521:Cyclopropanes; D004355:Drug Stability; D006358:Hot Temperature; D006863:Hydrogen-Ion Concentration; D008027:Light; D015394:Molecular Structure; D011804:Quinolines / Q000737:chemistry*; D012996:Solutions; D012997:Solvents / Q000737:chemistry; D013440:Sulfides; D013607:Tablets
D000085:Acetates; D018927:Anti-Asthmatic Agents; D002021:Buffers; D003521:Cyclopropanes; D011804:Quinolines; D012996:Solutions; D012997:Solvents; D013440:Sulfides; D013607:Tablets; C093875:montelukast